Premium
Protection against L‐ NAME ‐induced reduction in cardiac output persists even after cessation of angiotensin‐converting enzyme inhibitor treatment
Author(s) -
Biwer L. A.,
Broderick T. L.,
Xu H.,
Carroll C.,
Hale T. M.
Publication year - 2013
Publication title -
acta physiologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.591
H-Index - 116
eISSN - 1748-1716
pISSN - 1748-1708
DOI - 10.1111/j.1748-1716.2012.02474.x
Subject(s) - angiotensin converting enzyme , reduction (mathematics) , pharmacology , enzyme , medicine , angiotensin ii , chemistry , renin–angiotensin system , endocrinology , biochemistry , receptor , blood pressure , geometry , mathematics
Aim We have demonstrated that short‐term angiotensin‐converting enzyme ( ACE ) inhibition in adult spontaneously hypertensive rats produces cardiac changes that persist following cessation of treatment that result in a reduced inflammatory, proliferative and fibrotic response to the nitric oxide synthase inhibitor N ω ‐Nitro‐ l ‐arginine methyl ester (L‐ NAME ). The present study examines whether prior ACE inhibition with enalapril also protects against L‐ NAME ‐induced cardiac dysfunction. Methods Rats were treated with enalapril (Enal + L) or tap water (Con, Con + L) for 2 weeks followed by a 2‐week washout period. At this point, Con + L and Enal + L rats were treated with L‐ NAME for 10 days. Hearts were perfused in the working mode, mean arterial pressure ( MAP ) was assessed via radiotelemetry, and myocardial injury was evaluated in hematoxylin and eosin‐stained sections. Results L‐ NAME increased MAP by a similar magnitude in Con + L and Enal + L. L‐ NAME ‐induced statistically significant decreases in flow‐mediated functional parameters in Con + L rats including cardiac output, stroke volume and coronary flow. This was prevented by prior enalapril treatment. Prior enalapril did not prevent L ‐ NAME ‐induced myocardial injury, but may have lessened the degree of it. Regardless of treatment, changes in cardiac function did not correlate with myocardial injury. Conclusion Despite equivalent impact on MAP and incidence of myocardial infarction, prior enalapril treatment resulted in the preservation of cardiac function following L‐ NAME . Understanding the mechanisms by which transient ACE inhibition protects against reductions in cardiac function in the absence of ongoing treatment may reveal novel targets for heart failure treatment.